Luminex

The researchers hope that their results illustrate the potential of adopting Luminex in the context of other studies seeking an equivalent, higher-throughput alternative to LA.

Luminex reported $58.1 million in revenues compared to $55.2 million in the year-ago period and essentially on par with analysts' consensus estimate of $58.3 million.

The xTAG CYP2D6 kit runs on the Luminex 100/200 instrument and helps physicians determine drug treatment strategies. 

San Francisco

Officials from Luminex and BioNano Genomics provided strategic updates at the conference.

Trends included expanding test menus and a possible tipping point for point-of-care.

General Electric has been awarded

NEW YORK (GenomeWeb) — Luminex executives this week informed investors that the company has pushed back the commercialization timeline of Aries, the sample-to-answer molecular diagnostics system it has been developing for lower-throughput clinical laboratories as a complement to its higher-throug

NEW YORK (GenomeWeb) — Luminex reported after the close of the market Monday a 12 percent spike in third quarter revenues driven primarily by growth in assay sales across all major product categories.

Patrick Balthrop has retired as president and CEO of Luminex, and Nachum Shamir has been named as the new president and CEO, the company said this week.

NEW YORK (GenomeWeb) — Researchers at Johns Hopkins University have performed the first validation of the Cepheid Xpert Flu assay in a population of emergency room patients with acute undifferentiated respiratory illness.

Pages

An analysis of UK Biobank data finds hemochromatosis to be more prevalent than thought, according to the BBC.

An analysis finds that female biomedical researchers receive fewer prizes than male ones, and when they do win prizes, they are less prestigious.

In Nature this week: improved genomic analysis using a graph genome reference, tumor mutational burden could predict clinical response to immune checkpoint inhibitors, and more.

Federal researchers tell the Los Angeles Times that the shutdown is causing missed research opportunities as they try to keep their experiments going.